July 16: The Week in Cancer News
A study measures the global impact of alcohol on cancer incidence, and more news of the week from Cancer Today.
Progress Against Cancer
A study measures the global impact of alcohol on cancer incidence, and more news of the week from Cancer Today.
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today Cancers that grow and disseminate to threaten life reside amid many types of noncancerous cells, including blood vessel cells, supportive cells called fibroblasts, and...
Study shows cancer centers can improve coordination with physicians’ practices in their networks, and more news of the week from Cancer Today.
A study sheds light on the link between red meat consumption and colorectal cancer, and more news of the week from Cancer Today.
A reporter discusses the elevated risk for early-onset colorectal cancer in Black men, and more news of the week from Cancer Today.
Most scientists, regardless of field or career stage, have faced difficulties networking and disseminating their research in the past year, with many conferences and symposia canceled. The popularization of virtual meetings has helped researchers overcome this hurdle and keep in touch with their peers. However, early-career researchers—who...
A targeted therapy improves disease-free survival when given to people with certain hereditary mutations after breast cancer surgery, and more news of the week from Cancer Today.
A study finds that many people with solid tumors mount an antibody response following COVID-19 vaccination, and more news of the week from Cancer Today.
Melanoma is an aggressive form of skin cancer. While it is less common than skin cancers like basal cell carcinoma or squamous cell carcinoma, it is much more deadly due to its tendency to...
The U.S. Preventive Services Task Force lowers its recommended age to begin colorectal cancer screening to 45, and more news of the week from Cancer Today.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now